These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17951319)

  • 41. Adult bone marrow-derived stem cells for organ regeneration and repair.
    Tögel F; Westenfelder C
    Dev Dyn; 2007 Dec; 236(12):3321-31. PubMed ID: 17685479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem-cell-based therapy and lessons from the heart.
    Passier R; van Laake LW; Mummery CL
    Nature; 2008 May; 453(7193):322-9. PubMed ID: 18480813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell therapy for acute myocardial infarction.
    Gulati R; Simari RD
    Med Clin North Am; 2007 Jul; 91(4):769-85; xiii. PubMed ID: 17640547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Stem cell therapy in chronic heart failure].
    Theiss HD; Franz WM
    Med Klin (Munich); 2006 Jan; 101(1):77-81. PubMed ID: 16418819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current practice and future perspectives of myocardial stem cell therapy].
    Balogh L; Czuriga I; Kristóf E; Edes I
    Orv Hetil; 2005 May; 146(20 Suppl 2):1110-20. PubMed ID: 15945240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular transplantation: future therapeutic options.
    Allan R; Kass M; Glover C; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):104-10. PubMed ID: 17284988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stem cell therapy: a new perspective in the treatment of patients with acute myocardial infarction.
    Meyer GP; Wollert KC; Drexler H
    Eur J Med Res; 2006 Oct; 11(10):439-46. PubMed ID: 17107878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Stem cell transfer in myocardial infarction].
    Dimmeler S; Zeiher AM
    Dtsch Med Wochenschr; 2006 Apr; 131(16):881-3. PubMed ID: 16625481
    [No Abstract]   [Full Text] [Related]  

  • 49. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences.
    Kinnaird T; Stabile E; Burnett MS; Epstein SE
    Circ Res; 2004 Aug; 95(4):354-63. PubMed ID: 15321945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-enhancement strategies for the treatment of ischemic heart disease.
    Seeger FH; Zeiher AM; Dimmeler S
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S110-3. PubMed ID: 17230207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell transplantation for post-ischemic heart failure.
    Vilquin JT; Marolleau JP; Hagege A; Menasche P; Fiszman M; Schwartz K
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1219-25. PubMed ID: 12611044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular cardiomyoplasty: what have we learned?
    Kao RL; Browder W; Li C
    Asian Cardiovasc Thorac Ann; 2009 Jan; 17(1):89-101. PubMed ID: 19515892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cell therapy: results in Cardiology].
    Menasché P
    Bull Acad Natl Med; 2009 Mar; 193(3):559-68; discussion 568-9. PubMed ID: 19883011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-based therapy for heart failure.
    Wollert KC; Drexler H
    Curr Opin Cardiol; 2006 May; 21(3):234-9. PubMed ID: 16601463
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of stem and progenitor cells in postmyocardial infarction patients.
    Liu X; Dauwe D; Patel A; Janssens S
    Minerva Cardioangiol; 2009 Apr; 57(2):219-31. PubMed ID: 19274031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transplantation of progenitor cells and regeneration of damaged myocardium: more facts or doubts? Insights from experimental and clinical studies.
    Piepoli MF
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):624-34. PubMed ID: 19491702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J; Huang Y; Takagawa J; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW; Su H
    J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trials in stem cell therapy: pitfalls and lessons for the future.
    Metharom P; Doyle B; Caplice NM
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S96-9. PubMed ID: 17230223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.